Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Population pharmacokinetics of oxaliplatin (85 mg/m2) in combination with 5-fluorouracil in patients with advanced colorectal cancer.

Kho Y, Jansman FG, Prins NH, Neef C, Brouwers JR.

Ther Drug Monit. 2006 Apr;28(2):206-11.

PMID:
16628132
2.

Clinical pharmacokinetics of oxaliplatin: a critical review.

Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E.

Clin Cancer Res. 2000 Apr;6(4):1205-18. Review.

3.

Oxaliplatin: pharmacokinetics and chronopharmacological aspects.

Lévi F, Metzger G, Massari C, Milano G.

Clin Pharmacokinet. 2000 Jan;38(1):1-21. Review.

PMID:
10668856
4.

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.

5.

[Pharmacokinetic properties of platinium derivatives].

Boisdron-Celle M, Lebouil A, Allain P, Gamelin E.

Bull Cancer. 2001 Aug;88 Spec No:S14-9. Review. French.

PMID:
11567909
6.

New insights into the biotransformation and pharmacokinetics of oxaliplatin.

Jerremalm E, Wallin I, Ehrsson H.

J Pharm Sci. 2009 Nov;98(11):3879-85. doi: 10.1002/jps.21732. Review.

PMID:
19340883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk